REVB — Revelation Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Revelation Biosciences Says Safety Monitoring Committee Recommends Continuing Evaluation Of Allergic Rhinitis Treatment
Revelation Biosciences slumps after therapy to prevent influenza fails in study
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:33 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:37 PM
NASDAQ RESUMED AT 12:02 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:57 AM
NASDAQ RESUMED AT 11:52 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:47 AM
NASDAQ RESUMED AT 01:39 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:34 PM
Brief: Petra Acquisition Announces Share Redemption Backstop And Forward Purchase Agreements In Revelation Biosciences Combination
Brief: Revelation Biosciences Inc Appoints Joseph A. Bellanti, M.D. To Scientific Advisory Board
Brief: Revelation Biosciences Inc Announces Initiation Of A Phase 2B Study To Assess Efficacy Of Intranasal Revtx-99
Brief: Revelation Biosciences Inc. Announces Creation And Appointments To Scientific Advisory Board
Brief: Revelation Biosciences Initiates Phase 1B Study Of Allergic Rhinitis And Chronic Nasal Congestion Treatment
Brief: Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, To Optimize Value Of Co's Diagnostic Tool, REVID